SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013418
Filing Date
2022-08-12
Accepted
2022-08-12 09:57:33
Documents
78
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q casi-20220630x10q.htm   iXBRL 10-Q 1644149
2 EX-4.1 casi-20220630xex4d1.htm EX-4.1 43135
3 EX-10.1 casi-20220630xex10d1.htm EX-10.1 839242
4 EX-10.2 casi-20220630xex10d2.htm EX-10.2 119772
5 EX-10.3 casi-20220630xex10d3.htm EX-10.3 79013
6 EX-10.4 casi-20220630xex10d4.htm EX-10.4 68354
7 EX-31.1 casi-20220630xex31d1.htm EX-31.1 12626
8 EX-31.2 casi-20220630xex31d2.htm EX-31.2 12460
9 EX-32.1 casi-20220630xex32d1.htm EX-32.1 7173
10 EX-32.2 casi-20220630xex32d2.htm EX-32.2 7229
  Complete submission text file 0001558370-22-013418.txt   8462370

Data Files

Seq Description Document Type Size
11 EX-101.SCH casi-20220630.xsd EX-101.SCH 55426
12 EX-101.CAL casi-20220630_cal.xml EX-101.CAL 59957
13 EX-101.DEF casi-20220630_def.xml EX-101.DEF 192761
14 EX-101.LAB casi-20220630_lab.xml EX-101.LAB 352074
15 EX-101.PRE casi-20220630_pre.xml EX-101.PRE 312600
72 EXTRACTED XBRL INSTANCE DOCUMENT casi-20220630x10q_htm.xml XML 1380880
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 221158309
SIC: 2836 Biological Products, (No Diagnostic Substances)